6th SSO ASM Lung Track – Evolving Treatment Landscape in EGFRm+ NSCLC
Speaker: Prof John Wen-Cheng Chang
Document ID: PC-SG-101260
Dr. John Wen-Cheng CHANG recapitulates how TKIs have contributed to improved survival through generations, and how the treatment landscape is always evolving with the objective to give more time to patients.
Speaker
![](/sites/default/files/user_uploads/Dr_John-wen-cheng-chang.jpg)
John Wen-Cheng Chang, MD
Attending Physician, Associate Professor
Division of Hematology-Oncology, Department of Internal Medicine,
Chang Gung Memorial Hospital-Linkou Branch
Taoyuan, Taiwan
6th SSO ASM Lung Track – Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations
Speaker: Prof John Wen-Cheng Chang